Broad Institute wins crucial CRISPR decision at CAFC, but patent battle with University of California is far from over
The Federal Circuit’s judgment in favour of Broad in a much-anticipated CRISPR case is unlikely to bring the hard-fought patent dispute with its West Coast rival to an end just yet.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now